CYAPO-913

N/A

Report date: 2025/02/20 16:46:46

Base Information

Drug NameCYAPO-913
Drug Alias NameCYAPO-913
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFibroBiologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFibroBiologics Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A